These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 17362525)

  • 1. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study.
    Kofoed K; Andersen O; Kronborg G; Tvede M; Petersen J; Eugen-Olsen J; Larsen K
    Crit Care; 2007; 11(2):R38. PubMed ID: 17362525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.
    Xiao Y; Luo H; Zhou B; Dai X; Huang J; Duan L; You Y; Zhang W; Zhao H; Xie Y; Zhou Y; Ning W; Li T; Liu S; Zhu H; Xie X; Jiang Y; Wu S; He W; Li Y
    Rheumatol Int; 2017 Apr; 37(4):585-592. PubMed ID: 27878344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic stone protein as a novel marker for neonatal sepsis.
    Schlapbach LJ; Graf R; Woerner A; Fontana M; Zimmermann-Baer U; Glauser D; Giannoni E; Roger T; Müller C; Nelle M; Stocker M
    Intensive Care Med; 2013 Apr; 39(4):754-63. PubMed ID: 23296629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome.
    Hoenigl M; Raggam RB; Wagner J; Valentin T; Leitner E; Seeber K; Zollner-Schwetz I; Krammer W; Prüller F; Grisold AJ; Krause R
    Clin Biochem; 2013 Feb; 46(3):225-9. PubMed ID: 23159293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor.
    Kofoed K; Eugen-Olsen J; Petersen J; Larsen K; Andersen O
    Eur J Clin Microbiol Infect Dis; 2008 May; 27(5):375-83. PubMed ID: 18197443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study.
    Su L; Han B; Liu C; Liang L; Jiang Z; Deng J; Yan P; Jia Y; Feng D; Xie L
    BMC Infect Dis; 2012 Jul; 12():157. PubMed ID: 22809118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study.
    Gaïni S; Koldkjaer OG; Møller HJ; Pedersen C; Pedersen SS
    Crit Care; 2007; 11(4):R76. PubMed ID: 17625012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of decoy receptor 3 combined with procalcitonin and soluble urokinase-type plasminogen activator receptor for sepsis.
    Zhao JJ; Lou XL; Chen HW; Zhu FT; Hou YQ
    Cell Mol Biol Lett; 2018; 23():22. PubMed ID: 29760745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis.
    Ljungström L; Pernestig AK; Jacobsson G; Andersson R; Usener B; Tilevik D
    PLoS One; 2017; 12(7):e0181704. PubMed ID: 28727802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases.
    Lin CH; Hsieh SC; Keng LT; Lee HS; Chang HT; Liao WY; Ho CC; Yu CJ
    PLoS One; 2016; 11(4):e0153938. PubMed ID: 27096761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein, procalcitonin and the lab-score for detecting serious bacterial infections in febrile children at the emergency department: a prospective observational study.
    Nijman RG; Moll HA; Smit FJ; Gervaix A; Weerkamp F; Vergouwe Y; de Rijke YB; Oostenbrink R
    Pediatr Infect Dis J; 2014 Nov; 33(11):e273-9. PubMed ID: 25093971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The accuracy of C-reactive protein, procalcitonin, and s-TREM-1 in the prediction of serious bacterial infection in neonates.
    Stein M; Schachter-Davidov A; Babai I; Tasher D; Somekh E
    Clin Pediatr (Phila); 2015 May; 54(5):439-44. PubMed ID: 25294884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of dynamics serum sCD163, sTREM-1, PCT, and CRP in differentiating sepsis, severity assessment, and prognostic prediction.
    Su L; Feng L; Song Q; Kang H; Zhang X; Liang Z; Jia Y; Feng D; Liu C; Xie L
    Mediators Inflamm; 2013; 2013():969875. PubMed ID: 23935252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis.
    Gibot S; Cravoisy A; Kolopp-Sarda MN; Béné MC; Faure G; Bollaert PE; Levy B
    Crit Care Med; 2005 Apr; 33(4):792-6. PubMed ID: 15818107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome.
    Raggam RB; Wagner J; Prüller F; Grisold A; Leitner E; Zollner-Schwetz I; Valentin T; Krause R; Hoenigl M
    J Intern Med; 2014 Dec; 276(6):651-8. PubMed ID: 24645798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
    Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
    J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis.
    Huang CT; Lee LN; Ho CC; Shu CC; Ruan SY; Tsai YJ; Wang JY; Yu CJ
    J Infect; 2014 May; 68(5):440-7. PubMed ID: 24393650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble urokinase-type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study.
    Uusitalo-Seppälä R; Huttunen R; Tarkka M; Aittoniemi J; Koskinen P; Leino A; Vahlberg T; Rintala EM
    J Intern Med; 2012 Sep; 272(3):247-56. PubMed ID: 22755554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble receptor for urokinase plasminogen activator in community-acquired pneumonia in children.
    Wrotek A; Pawlik K; Jackowska T
    Adv Exp Med Biol; 2013; 788():329-34. PubMed ID: 23835994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Procalcitonin Assays to Predict Serious Bacterial Infection in Young Febrile Infants.
    Milcent K; Faesch S; Gras-Le Guen C; Dubos F; Poulalhon C; Badier I; Marc E; Laguille C; de Pontual L; Mosca A; Nissack G; Biscardi S; Le Hors H; Louillet F; Dumitrescu AM; Babe P; Vauloup-Fellous C; Bouyer J; Gajdos V
    JAMA Pediatr; 2016 Jan; 170(1):62-9. PubMed ID: 26595253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.